Jinyu Bio-Technology Co (SHSE:600201) Beta: 1.4036 (As of Jun. 26, 2026)


SHSE:600201 Jinyu Bio-Technology Co Ltd SHSE:600201
68 GF Score
Price ¥11.44
GF Value ¥8.19
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Jinyu Bio-Technology Co Beta?

Jinyu Bio-Technology Co SHSE:600201 -5.30% 68 Beta is 1.4036 as of Jun. 26, 2026. GuruFocus rates SHSE:600201 with a GF Score™ of 68/100 and a GF Value™ of ¥8.19 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Jinyu Bio-Technology Co's Beta is 1.4036.


Jinyu Bio-Technology Co  (SHSE:600201) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Jinyu Bio-Technology Co Beta Related Terms


Jinyu Bio-Technology Co Beta Historical Data

* Premium members only.

The historical data trend for Jinyu Bio-Technology Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinyu Bio-Technology Co Beta Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.87 1.15 1.47 1.40

Jinyu Bio-Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 1.35 1.24 1.40 1.39

SHSE:600201 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Jinyu Bio-Technology Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinyu Bio-Technology Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's Beta distribution charts can be found below:

* The bar in red indicates where Jinyu Bio-Technology Co's Beta falls into.


SHSE:600201
68GF Score
Jinyu Bio-Technology Co Ltd SHSE:600201
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinyu Bio-Technology Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.4036 mean?
Jinyu Bio-Technology Co (SHSE:600201) has a Beta of 1.4036 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Jinyu Bio-Technology Co and its competitors.
Is Jinyu Bio-Technology Co's Beta too high?
Jinyu Bio-Technology Co's current Beta is 1.4036. Overall, Jinyu Bio-Technology Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Beta compare to VRTX and REGN?
Jinyu Bio-Technology Co's Beta of 1.4036 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current Beta is 1.4036. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.19, compared to a current price of ¥11.44 — trading 39.7% above its estimated fair value. The current Beta is 1.4036. Jinyu Bio-Technology Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Beta is 1.4036 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?

Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥11.44 is trading 39.7% above its estimated GF Value™ of ¥8.19. GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600201:

  • Beta: 1.4036
  • GF Value™: ¥8.19 vs. price of ¥11.44 (39.7% above fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jinyu Bio-Technology Co Business Description

Address No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
68GF Score

Get the complete analysis for SHSE:600201

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.44
Price
¥8.19
GF Value